The University of Oregon is constructing the second phase of the Phil and Penny Knight Campus for Accelerating Scientific Impact in Eugene. Designed by ZGF Architects, Building 2 will double capacity for the research and development of biomedical technologies and expand space for academic programs, engineering, and applied science.
The University of Virginia is constructing the $350 million Paul and Diane Manning Institute for Biotechnology in Charlottesville to catalyze breakthroughs in the fields of cellular therapy, gene therapy, nanotechnology, and drug delivery. Designed by Elkus Manfredi Architects, the flexible building will provide 355,809 sf of space for leading-edge laboratories, core facilities, advanced manufacturing suites, and clinical environments.
The University of Alabama at Birmingham opened the Altec/Styslinger Genomic Medicine and Data Sciences Building in October of 2025. Designed by William Blackstock Architects, the $78 million project involved the renovation and expansion of the existing Lyons-Harrison Research Building to accommodate leading-edge labs, computational suites, meeting rooms, offices, and purpose-built venues for innovation and collaboration.
The University of North Texas is constructing the Science and Technology Building on its Denton campus. Designed by SmithGroup, the $109 million facility will serve the College of Science, the College of Engineering, the College of Health and Public Service, and other departments and programs.
Penn Medicine opened a $376 million facility in September of 2025 in Philadelphia to drive pioneering research in autoimmune disorders. Positioned atop an existing 250,000-sf office tower, the eight-story overbuild features wet laboratories, a vivarium, and a BSL-3 lab for the processing of infectious disease specimens. The 217,000-sf expansion was designed by Perkins&Will to stimulate collaboration and accelerate the development of new treatment modalities for conditions such as arthritis, lupus, diabetes, and multiple sclerosis.
The University of Arkansas opened the Institute for Integrative & Innovative Research (I³R) in August of 2025 on its Fayetteville campus. Designed by HGA and Hufft, the $137.6 million facility will accelerate cross-disciplinary research to foster convergence across the public and private sectors and address pressing problems in domains such as medicine, food systems, and cyber technologies. The 144,000-sf building accommodates five wings.
Brown University is constructing the William A. and Ami Kuan Danoff Laboratories in Providence’s Jewelry District to support integrated life sciences research. The 300,000-sf facility was designed by TenBerke and Ballinger to catalyze innovation and the commercialization of impactful scientific and medical breakthroughs. The seven-story building will provide six levels of wet and dry laboratories and research cores for programs in biology, medicine, neuroscience, bioengineering, and public health.
In the span of 16 months, Seattle’s Fred Hutch Cancer Center formulated and implemented a space realignment initiative that divested 30,000 sf of leased space, generated $2 million in savings and another $2 million in cost avoidance, and impacted approximately 1,400 people, 20% of its 7,000-member workforce.
Indiana University opened the $230 million Medical Education and Research Building (MERB) in June of 2025 in Indianapolis. Representing the largest construction project in the history of the School of Medicine, the 11-story, 326,200-gsf complex was designed by Perkins&Will and Browning Day as a dynamic hub for instruction, training, and discovery.
Gilead Sciences is constructing the Cancer Research Center in Foster City to accelerate the creation of novel solutions for pressing medical challenges. Driven by the company's enterprise master plan, the project is part of a strategic initiative to develop an internal research infrastructure that advances discovery in key focus areas and brings new technological capabilities in-house. The 182,000-sf facility was designed by Gensler to catalyze synergies between 54 clinical programs spanning oncology, inflammation, and virology.
Cornell University celebrated the opening of Atkinson Hall in April of 2025 in Ithaca, N.Y. Designed by Lake|Flato and SWBR as a nexus for impact-driven research across disciplinary boundaries, the $54 million facility addresses the diverse needs of four unique programs, all of which are university-wide in scope.
Biogen is planning to centralize its operations with a 580,000-sf global headquarters in the Kendall Common development in Cambridge, Mass. Representing a 15-year lease agreement, the facility’s strategic location will strengthen existing partnerships with MIT in research, education, and commercialization, and build on Biogen’s legacy as an integral part of the Kendall Square ecosystem.
Louisiana State University Health Shreveport (LSUHS) will establish the Cancer and Cardiovascular Research Facility to showcase the institution’s innovative activities and groundbreaking discoveries. Representing an investment of approximately $50 million, the first phase of the adaptive reuse project involves the renovation of 60,000 sf in a former 160,000-sf department store to provide open labs, offices, education and conference rooms, and support areas.
The Medical College of Wisconsin is constructing the $153 million Center for Cancer Discovery on the Milwaukee Regional Medical Center campus. Centralizing the university’s cancer research programs under one roof, this dynamic hub will catalyze discoveries in cancer biology, expand clinical trials, and create groundbreaking treatments for patients.
The 2024 SEFA Lab of the Year was awarded to the new Roche Pharma Research and Early Development (pRED) Center in Basel, Switzerland, that opened in September 2024 as a state-of-the-art research center dedicated to the discovery and development of groundbreaking drugs. The pRED Center exemplifies the future of transformative research by fostering innovation and collaboration, and embodying Roche’s commitment to advancing global healthcare and delivering life-changing treatments.
